Cardiothoracic manifestations of neuroendocrine tumours

被引:9
作者
Mandegaran, Ramin [1 ]
David, Sarojini [2 ]
Screaton, Nicholas [3 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London, England
[2] Lewisham & Greenwich NHS Trust, Univ Hosp Lewisham, Dept Radiol, London, England
[3] Papworth Everard Hosp, Papworth Hosp NHS Fdn Trust, Dept Radiol, Cambridge, England
关键词
CARCINOID HEART-DISEASE; CELL LUNG-CANCER; IDIOPATHIC DIFFUSE HYPERPLASIA; ENDOCRINE NEOPLASIA TYPE-1; 3-DIMENSIONAL ECHOCARDIOGRAPHY; THYMIC CARCINOIDS; CT; CLASSIFICATION; MANAGEMENT; SPECTRUM;
D O I
10.1259/bjr.20150787
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Cardiothoracic neuroendocrine tumour (NET) manifestations encompass a vast disease spectrum. Pulmonary neuroendocrine tumours represent a range of tumour grade and differentiation characteristics from pre-malignant diffuse neuroendocrine cell hyperplasia, well-differentiated, low-grade carcinoid tumours with excellent outcomes, through to high-grade small-cell lung carcinoma and large-cell neuroendocrine carcinoma with poor prognoses. Rarer thymic NETs represent a similarly wide neoplastic spectrum. Cardiac carcinoid is a paraneoplastic manifestation of the carcinoid syndrome and often the cause of mortality in NETs with hepatic metastases. Cardiothoracic NET manifestations are reviewed herein from a radiologists' perspective, discussing the diverse clinical presentations, spectrum of neoplastic and paraneoplastic manifestations, imaging features and treatment options.
引用
收藏
页数:14
相关论文
共 103 条
[41]  
2
[42]   68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT [J].
Gabriel, Michael ;
Decristoforo, Clemens ;
Kendler, Dorota ;
Dobrozemsky, Georg ;
Heute, Dirk ;
Uprimny, Christian ;
Kovacs, Peter ;
Von Guggenberg, Elisabeth ;
Bale, Reto ;
Virgolini, Irene J. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) :508-518
[43]  
Gandhi Leena, 2006, J Natl Compr Canc Netw, V4, P631
[44]   Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1 [J].
Gibril, F ;
Chen, YJ ;
Schrump, DS ;
Vortmeyer, A ;
Zhuang, ZP ;
Lubensky, IA ;
Reynolds, JC ;
Louie, A ;
Entsuah, LK ;
Huang, K ;
Asgharian, B ;
Jensen, RT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) :1066-1081
[45]   Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors [J].
Gosney, JR .
CHEST, 2004, 125 (05) :108S-108S
[46]   Octreoscan in patients with bronchial carcinoid tumours [J].
Granberg, D ;
Sundin, A ;
Janson, ET ;
Öberg, K ;
Skogseid, B ;
Westlin, JE .
CLINICAL ENDOCRINOLOGY, 2003, 59 (06) :793-799
[47]   Bronchopulmonary neuroendocrine tumors [J].
Gustafsson, Bjorn I. ;
Kidd, Mark ;
Chan, Anthony ;
Malfertheiner, Max V. ;
Modlin, Irvin M. .
CANCER, 2008, 113 (01) :5-21
[48]   Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute [J].
Han, Boram ;
Sun, Jong-Mu ;
Ahn, Jin Seok ;
Park, Keunchil ;
Ahn, Myung-Ju .
MEDICAL ONCOLOGY, 2013, 30 (01)
[49]  
Ito T, 1997, LAB INVEST, V77, P449
[50]   Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity [J].
Iyoda, A ;
Hiroshima, K ;
Moriya, Y ;
Mizobuchi, T ;
Otsuji, M ;
Sekine, Y ;
Shibuya, K ;
Iizasa, T ;
Saitoh, Y ;
Fujisawa, T .
ANNALS OF THORACIC SURGERY, 2004, 77 (06) :1891-1895